Cargando...
Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
OBJECTIVE: To explore the efficacy of botulinum toxin type A (BTX-A) therapy in relieving anxiety and depression in patients with hemifacial spasm (HFS) and benign essential blepharospasm (BEB). PATIENTS AND METHOD: Ninety idiopathic HFS patients and 90 BEB patients were enrolled. The anxiety and de...
Guardado en:
| Publicado en: | Neuropsychiatr Dis Treat |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6304258/ https://ncbi.nlm.nih.gov/pubmed/30587995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S181820 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|